Insider Selling: Phreesia, Inc. (NYSE:PHR) COO Sells 2,681 Shares of Stock

Phreesia, Inc. (NYSE:PHR) COO Evan Roberts sold 2,681 shares of the stock in a transaction dated Wednesday, January 8th. The shares were sold at an average price of $27.95, for a total value of $74,933.95. Following the completion of the transaction, the chief operating officer now owns 769,993 shares of the company’s stock, valued at $21,521,304.35. This represents a 0.35 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.

Evan Roberts also recently made the following trade(s):

• On Monday, January 6th, Evan Roberts sold 2,873 shares of Phreesia stock. The stock was sold at an average price of $26.61, for a total transaction of $76,450.53.
• On Tuesday, October 15th, Evan Roberts sold 1,843 shares of Phreesia stock. The stock was sold at an average price of $21.03, for a total value of $38,758.29.

Phreesia Stock Down 5.9 %

Shares of NYSE PHR traded down $1.68 during mid-day trading on Friday, reaching $26.75. 625,124 shares of the company’s stock traded hands, compared to its average volume of 446,504. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.74 and a quick ratio of 1.77. Phreesia, Inc. has a 1-year low of $17.07 and a 1-year high of $29.16. The stock has a market cap of $1.55 billion, a P/E ratio of -18.20 and a beta of 0.94. The business has a 50-day simple moving average of $22.70 and a 200 day simple moving average of $22.57.

Phreesia (NYSE:PHR) last issued its quarterly earnings data on Monday, December 9th. The company reported ($0.25) EPS for the quarter, topping the consensus estimate of ($0.29) by $0.04. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The firm had revenue of $106.80 million during the quarter, compared to the consensus estimate of $106.33 million. During the same period in the prior year, the business posted ($0.58) earnings per share. The company’s quarterly revenue was up 16.6% compared to the same quarter last year. On average, analysts expect that Phreesia, Inc. will post -1.16 EPS for the current fiscal year.

Hedge Funds Weigh In On Phreesia

A number of hedge funds and other institutional investors have recently made changes to their positions in PHR. Versor Investments LP bought a new position in Phreesia in the 3rd quarter worth approximately $694,000. Zacks Investment Management purchased a new stake in Phreesia during the 3rd quarter worth about $631,000. Sei Investments Co. boosted its stake in Phreesia by 135.3% in the 2nd quarter. Sei Investments Co. now owns 165,327 shares of the company’s stock worth $3,505,000 after purchasing an additional 95,058 shares during the period. State Street Corp grew its holdings in Phreesia by 7.1% during the 3rd quarter. State Street Corp now owns 1,327,586 shares of the company’s stock valued at $30,256,000 after buying an additional 88,517 shares in the last quarter. Finally, Barclays PLC increased its position in shares of Phreesia by 83.6% during the third quarter. Barclays PLC now owns 94,929 shares of the company’s stock valued at $2,163,000 after buying an additional 43,225 shares during the period. 92.10% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research firms recently commented on PHR. Truist Financial lifted their price objective on Phreesia from $31.00 to $34.00 and gave the stock a “buy” rating in a research note on Wednesday, December 11th. Robert W. Baird decreased their price objective on shares of Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a research report on Wednesday, December 11th. JMP Securities reaffirmed a “market outperform” rating and set a $30.00 price target on shares of Phreesia in a research report on Tuesday, December 10th. KeyCorp lifted their price objective on Phreesia from $28.00 to $30.00 and gave the stock an “overweight” rating in a research report on Wednesday. Finally, Needham & Company LLC restated a “buy” rating and set a $29.00 target price on shares of Phreesia in a research report on Friday. Twelve analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus target price of $31.00.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.